Google’s Verily eyes 2021 growth after $700m funding roundVerily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors Share XGoogle’s Verily eyes 2021 growth after $700m funding roundhttps://pharmaphorum.com/news/google-verily-onduo-2021-growth-funding/
Verily plans digital ophthalmology joint venture with SantenVerily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen. The joint venture Share XVerily plans digital ophthalmology joint venture with Santenhttps://pharmaphorum.com/news/verily-plans-ophthalmology-joint-venture-with-santen/
Verily signs up four big pharmas to its clinical trials platformVerily, the life sciences company owned by Google parent Alphabet, has teamed up with Novartis, Sanofi, Otsuka, and Share XVerily signs up four big pharmas to its clinical trials platformhttps://pharmaphorum.com/news/verily-signs-up-four-big-pharmas-to-its-clinical-trials-platform/
Verily/Google use algorithm to detect diabetic eye diseaseVerily and Google have developed a machine learning algorithm that can automatically detect diabetes-related eye disease, which could Share XVerily/Google use algorithm to detect diabetic eye diseasehttps://pharmaphorum.com/news/verily-google-use-algorithm-to-diabetic-eye-disease/
Verily builds US drug rehab campus amid opioid crisisAlphabet’s life sciences division Verily is building a rehab campus to help combat the opioid crisis, according to Share XVerily builds US drug rehab campus amid opioid crisishttps://pharmaphorum.com/news/verily-builds-us-drug-rehab-campus-amid-opioid-crisis/
Apple and Verily make further inroads into health wearable techApple and rival Verily – a subsidiary of Google’s parent company Alphabet – have invested in two major Share XApple and Verily make further inroads into health wearable techhttps://pharmaphorum.com/news/apple-and-verily-make-further-inroads-into-health-wearable-tech/
Alphabet’s smart watch ECG gets FDA backingAlphabet’s life science subsidiary Verily is the latest firm to get an electrocardiogram (ECG) watch approved by the Share XAlphabet’s smart watch ECG gets FDA backinghttps://pharmaphorum.com/news/alphabets-smart-watch-ecg-gets-fda-backing/
ResMed joins Google to research sleep apnoea therapiesResMed combines apnoea expertise with Verily’s AI capabilities Share XResMed joins Google to research sleep apnoea therapieshttps://pharmaphorum.com/news/resmed-joins-google-to-research-sleep-apnoea-therapies/
Gilead to collaborate with Google’s Verily in inflammatory diseasesGilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological Share XGilead to collaborate with Google’s Verily in inflammatory diseaseshttps://pharmaphorum.com/news/gilead-google-verily-inflammatory-disease-research/